2016
DOI: 10.1517/14656566.2016.1154536
|View full text |Cite
|
Sign up to set email alerts
|

Psychopharmacological interventions in autism spectrum disorder

Abstract: Psychopharmacological treatment of core and associated symptoms in ASD is challenging, in large part because of the heterogeneity in the presentation of ASD. Furthermore, children and adolescents with ASD are more vulnerable to the side effects of psychopharmacological intervention than their age-matched, typically developing counterparts. Currently, risperidone and aripiprazole are the only medications that have been (relatively) reliably shown to help treat certain symptom clusters associated with ASD, namel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
54
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 101 publications
(54 citation statements)
references
References 145 publications
0
54
0
Order By: Relevance
“…Elevations in blood levels of neurotransmitters and their derivatives are common in autism [15]. The primary existing pharmacologic compounds that have demonstrated efficacy in autism have been found to decrease irritability and have modes of action based on down regulating neurotransmitter receptors [16].…”
Section: Hypothesis Sulfur Compounds In Autism Biochemistrymentioning
confidence: 99%
“…Elevations in blood levels of neurotransmitters and their derivatives are common in autism [15]. The primary existing pharmacologic compounds that have demonstrated efficacy in autism have been found to decrease irritability and have modes of action based on down regulating neurotransmitter receptors [16].…”
Section: Hypothesis Sulfur Compounds In Autism Biochemistrymentioning
confidence: 99%
“…Current available treatment options are largely based on addressing comorbid psychiatric, neurological, or medical conditions, as core symptoms of autism are often refractory to current pharmaco-therapeutic options (Ji and Findling 2015). Thus, many attempts to develop novel treatments have been driven towards ameliorating the core features with hopes to possibly change the natural course of the illness (Accordino et al 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Here, we review some of the physiology-and pharmacology-based interventions for ASD along with recent-advances in ASD treatment and their effectiveness in treating ASD. These include selective serotonin receptor-uptake inhibitors (SSRIs), antidepressants, antipsychotic drugs, stimulants, dietary supplements, and special diets [7,8]. Very limited data are currently available regarding the long-term effectiveness and side-effects of these treatments for ASD.…”
Section: Introductionmentioning
confidence: 99%